Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Lymphoma 1 Leukemia 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1 Hemangioma, Capillary 1

Interventions

Cyclophosphamide 254 fludarabine phosphate 165 Cytarabine 160 Methotrexate 128 Busulfan 115 Filgrastim 111 fludarabine 102 Peripheral Blood Stem Cell Transplantation 96 Rituximab 94 Antilymphocyte Serum 83 Etoposide 81 Cyclosporine 75 Tacrolimus 74 Mycophenolic Acid 73 Whole-Body Irradiation 72 Radiotherapy 70 Melphalan 66 Vincristine 55 Dexamethasone 54 Granulocyte Colony-Stimulating Factor 50 Methylprednisolone 48 Azacitidine 44 Alemtuzumab 42 Imatinib Mesylate 41 Clofarabine 41 sargramostim 40 Idarubicin 36 Daunorubicin 36 Cord Blood Stem Cell Transplantation 36 Thiotepa 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leukemia × Clozapine × Clear all

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡